About Bird Rock Bio
Bird Rock Bio is a company based in San Diego (United States) founded in 2008 was acquired by Skye Bioscience in August 2023. Bird Rock Bio has raised $62.55 million across 7 funding rounds from investors including SVB, Johnson & Johnson and Merck. The company has 14 employees as of December 31, 2022. Bird Rock Bio operates in a competitive market with competitors including argenx, MacroGenics, Alexion, Zai Lab and Kodiak Sciences, among others.
- Headquarter San Diego, United States
- Employees 14 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ruiyi, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$62.55 M (USD)
in 7 rounds
-
Latest Funding Round
$2.5 M (USD), Series B
Jan 06, 2017
-
Investors
SVB
& 9 more
-
Employee Count
14
as on Dec 31, 2022
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Bird Rock Bio
Bird Rock Bio has successfully raised a total of $62.55M across 7 strategic funding rounds. The most recent funding activity was a Series B round of $2.5 million completed in January 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Bird Rock Bio
Bird Rock Bio has secured backing from 10 investors, including institutional and venture fund investors. Prominent investors backing the company include SVB, Johnson & Johnson and Merck.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund backed incubator focused on the healthcare startups
|
Locked | Locked | Locked | |
|
Healthcare impact investments are managed by Apposite Capital.
|
Locked | Locked | Locked | |
|
A biotechnology venture capital firm investing in innovative science.
|
Locked | Locked | Locked |
Investor details for Bird Rock Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bird Rock Bio
Investment portfolio details for Bird Rock Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bird Rock Bio
Detailed financials for Bird Rock Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bird Rock Bio Comparisons
Peer comparison for Bird Rock Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bird Rock Bio
Bird Rock Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as argenx, MacroGenics, Alexion, Zai Lab and Kodiak Sciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment.
|
|
| Locked | Locked | Locked |
A biopharmaceutical company focused on cancer therapeutics development.
|
|
| Locked | Locked | Locked |
Therapies for rare and devastating diseases are developed by Alexion.
|
|
| Locked | Locked | Locked |
Antibody-based therapies for cancers and inflammatory diseases are developed.
|
|
| Locked | Locked | Locked |
Therapeutics for retinal diseases are developed by the company.
|
|
| Locked | Locked | Locked |
Antibody-based drugs for primary myopathies are developed and targeted.
|
Detailed competitors of Bird Rock Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bird Rock Bio
Complete news archive for Bird Rock Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bird Rock Bio
Bird Rock Bio was founded in 2008.
Bird Rock Bio is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Bird Rock Bio is a funded company, having raised a total of $62.55M across 7 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Bird Rock Bio is 14.
Bird Rock Bio was founded in 2008 in San Diego, United States, within the biotechnology sector. Novel antibodies directed at G-Protein Coupled Receptors, which have been validated using small molecules, are discovered and developed. Operations center on biologic therapeutics for rheumatoid arthritis, metabolic diseases, fibrosis, and nonalcoholic steatohepatitis, with activities conducted from the companys location in the United States.
Bird Rock Bio's top competitors include argenx, Zai Lab and Kodiak Sciences.
Bird Rock Bio has 10 investors. Key investors include SVB, Johnson & Johnson, Merck, Skye Bioscience, and 5AM Ventures.